Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuro-Oncology

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/neuonc/nop054PMID 20511192PMCID PMC2940677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates.

  2011cited by this paper
• Image-guided convection-enhanced delivery platform in the treatment of neurological diseases

  2011cited by this paper
• Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring.

  2008cited by this paper
• Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.

  2007cited by this paper
• Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

  2007cited by this paper
• INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING

  2007cited by this paper
• Multiforme : Implications for Targeted Therapies 2 in Glioblastoma α Expression of Interleukin-13 Receptor

  2007cited by this paper
• Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease

  2007cited by this paper
• Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review

  2007cited by this paper
• Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.

  2007cited by this paper
• Real-time Imaging and Quantification of Brain Delivery of Liposomes

  2006cited by this paper
• Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy

  2006cited by this paper
• Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.

  2005cited by this paper
• Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.

  2005cited by this paper
• Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.

  2004cited by this paper
• Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

  2004cited by this paper
• Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.

  2003cited by this paper
• Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

  2003cited by this paper
• Tumor regression mechanisms by IL‐13 receptor–targeted cancer therapy involve apoptotic pathways

  2003cited by this paper
• Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

  2003cited by this paper
• Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

  2003cited by this paper
• Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

  2003cited by this paper
• Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts.

  2002cited by this paper
• Interleukin‐13 receptor as a unique target for anti‐glioblastoma therapy

  2001cited by this paper
• Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.

  2000cited by this paper
• Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma

  2000cited by this paper
• Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time.

  1999cited by this paper
• Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.

  1999cited by this paper
• Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics.

  1999cited by this paper
• Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

  1998cited by this paper
• Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors

  1998cited by this paper
• Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.

  1997cited by this paper
• Receptor for Interleukin (IL) 13 Does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on Human Glioma Cells*

  1996cited by this paper
• Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

  1995cited by this paper
• Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995influential reference
• High-flow microinfusion: tissue penetration and pharmacodynamics.

  1994cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Teaching and testing technical skills.

  1993cited by this paper
• Morbidity and mortality of craniotomy for excision of supratentorial gliomas

  1988cited by this paper
• Neuro‐oncology

  1982cited by this paper

• Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma

  2026cites this paper
• CAR-T cell therapies are coming after glioblastoma: An overview of early phase clinical trials and future perspectives

  2026cites this paper
• Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma

  2026cites this paper
• Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain

  2026cites this paper
• Convection-Enhanced Delivery of Auristatin-Conjugated Layer-by-Layer Nanoparticles for Glioblastoma Treatment.

  2025cites this paper
• Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma

  2025cites this paper
• Therapeutic manipulation and bypass of the blood-brain barrier: powerful tools in glioma treatment.

  2025cites this paper
• Efficacy and Safety of Intra-arterial Chemoperfusion as Palliative Treatment of Symptomatic Primary Brain Malignancies.

  2025cites this paper
• Direct delivery of gene- and cell-based therapies to the nervous system. Image-Guided Biologic Therapies: Neurosurgeons Innovating Treatment Excellence Summit summary.

  2025cites this paper
• Self-assembling polypeptide-drug conjugates as innovative therapeutic candidates for glioblastoma treatment by enhancing intracranial residence time

  2025cites this paper
• Advances and challenges in CAR-T therapy for glioblastoma.

  2025cites this paper
• Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy.

  2025cites this paper
• Modern insights of nanotheranostics in the glioblastoma: An updated review.

  2025cites this paper
• Recent advances on brain drug delivery via nanoparticles: alternative future materials for neuroscience applications; a review

  2025cites this paper
• Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins

  2025cites this paper
• Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood–Brain Barrier and Blood–Tumor Barrier

  2025cites this paper
• Navigating the Central Nervous System (CNS): A Pharmacokinetic Approach to the Treatment of CNS Tumors, Glioblastoma Multiforme (GBM), in Particular

  2025cites this paper
• Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial

  2025cites this paper
• Using MRI to determine drug concentration in convection-enhanced Delivery: A Proof-of-Concept study.

  2025cites this paper
• Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions

  2025cites this paper
• Targeting the glioblastoma resection margin with locoregional nanotechnologies

  2025cites this paper
• Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling

  2025cites this paper
• Novel Clinical Trials and Approaches in the Management of Glioblastoma

  2024cites this paper
• Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

  2024cites this paper
• Adjuvant convection-enhanced delivery for the treatment of brain tumors

  2024cites this paper
• Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data

  2024cites this paper
• Consensus Review on Strategies to Improve Delivery Across the BBB Including Focused Ultrasound.

  2024cites this paper
• Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption

  2024influential citation
• Image-guided patient-specific optimization of catheter placement for convection-enhanced nanoparticle delivery in recurrent glioblastoma

  2024cites this paper
• Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases

  2024cites this paper
• Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities

  2024cites this paper
• Targeted Radionuclide Therapy in Glioblastoma.

  2024cites this paper
• Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models.

  2024cites this paper
• Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma

  2024cites this paper
• The role of radiotherapy in immunotherapy strategies in the central nervous system.

  2024cites this paper
• Improving glioma drug delivery: A multifaceted approach for glioma drug development

  2024cites this paper
• A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma

  2024cites this paper
• Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses

  2024cites this paper
• Immunotherapy of malignant gliomas: a modern view on the problem

  2024cites this paper
• Engineering advanced nanomedicines against central nervous system diseases

  2023cites this paper
• Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme

  2023cites this paper
• Autophagy Inhibition with Chloroquine Increased Pro-Apoptotic Potential of New Aziridine-Hydrazide Hydrazone Derivatives against Glioblastoma Cells

  2023cites this paper
• Toxic warhead-armed antibody for targeted treatment of glioblastoma.

  2023cites this paper
• MRI-aided SmartFlow convection delivery of DNX-2401: a pilot, prospective case series.

  2023cites this paper
• Phase 2 trials in the era of glioblastoma immunotherapy: New mechanisms of action, familiar challenges in trial design and tumor response assessment.

  2023cites this paper
• Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

  2023cites this paper
• Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma

  2023cites this paper
• Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors

  2023cites this paper
• PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).

  2023cites this paper
• Antibody drug conjugates for glioblastoma: current progress towards clinical use

  2023cites this paper
• Targeting glioblastoma multiforme using a novel fusion protein comprising interleukin-13 and staphylococcal enterotoxin B in vitro.

  2023cites this paper
• Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study

  2023cites this paper
• Overcoming the blood brain barrier in glioblastoma: Status and future perspective.

  2023cites this paper
• Advanced Temporally‐Spatially Precise Technologies for On‐Demand Neurological Disorder Intervention

  2023cites this paper
• Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time

  2023cites this paper
• Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives

  2023cites this paper
• Cancer Drug Delivery Systems Using Bacterial Toxin Translocation Mechanisms

  2023cites this paper
• Fifty years of DIPG: looking at the future with hope

  2023cites this paper
• Surgical Management and Advances in the Treatment of Glioma

  2023cites this paper
• H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics

  2023cites this paper
• Engineering the IL‐4/IL‐13 axis for targeted immune modulation

  2023cites this paper
• Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment.

  2023cites this paper
• Convection-Enhanced Delivery in Children: Techniques and Applications.

  2022cites this paper
• Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM

  2022cites this paper
• Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

  2022cites this paper
• Overcoming biophysical barriers with innovative therapeutic delivery approaches.

  2022cites this paper
• Infusion of Therapeutic Agents to the Brain (Convection-Enhanced Intraparenchymal Delivery)

  2022cites this paper
• Convection‐enhanced delivery with controlled catheter movement: A parametric finite element analysis

  2022cites this paper
• Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.

  2022cites this paper
• Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

  2022cites this paper
• IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma

  2022influential citation
• Constant Pressure Convection-Enhanced Delivery Increases Volume Dispersed with Catheter Movement in Agarose.

  2022cites this paper
• Glioblastoma: Current Status, Emerging Targets, and Recent Advances

  2022cites this paper
• Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy

  2022cites this paper
• Drug Delivery Across the Blood-Brain Barrier for the Treatment of Pediatric Brain Tumors - An Update.

  2022cites this paper
• PLGA-nano-encapsulated Disulfiram inhibits hypoxia-induced NFκB, cancer stem cells and targets glioblastoma in vitro and in vivo.

  2022cites this paper
• Glioma targeted therapy: insight into future of molecular approaches

  2022cites this paper
• Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches

  2022cites this paper
• Advances in local therapy for glioblastoma — taking the fight to the tumour

  2022cites this paper
• Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan

  2022cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Updates in intraoperative strategies for enhancing intra-axial brain tumor control.

  2022cites this paper
• Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms

  2022cites this paper
• 99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model

  2022cites this paper
• Locoregional infusion of IL13Rα2-specific immunotoxins in children and adults with high-grade glioma.

  2022cites this paper
• Loss of Interleukin-13-Receptor-Alpha-1 Induces Apoptosis and Promotes EMT in Pancreatic Cancer

  2022cites this paper
• Solid Fiber Inside of Capillary and Modified Fusion-Spliced Fiber Optic Microneedle Devices for Improved Light Transmission Efficiency.

  2022cites this paper
• Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer

  2021influential citation
• Novel Treatment Approaches for Brain Tumour from a Blood-Brain Barrier Perspective.

  2021cites this paper
• The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials.

  2021cites this paper
• Frontiers in the treatment of glioblastoma: Past, present and emerging.

  2021cites this paper
• Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges

  2021cites this paper
• Status Quo and Trends of Intra-Arterial Therapy for Brain Tumors: A Bibliometric and Clinical Trials Analysis

  2021cites this paper
• Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy

  2021cites this paper
• On the microstructural origin of brain white matter hydraulic permeability

  2021cites this paper
• Current Immunotherapeutic Strategies for the Treatment of Glioblastoma

  2021cites this paper
• Pediatric high‐grade glioma: moving toward subtype‐specific multimodal therapy

  2021cites this paper
• Antibody-drug conjugates for H3K27M-mutant diffuse midline gliomas: prospects and challenges.

  2021cites this paper
• Glioblastoma Multiforme (GBM): An overview of current therapies and mechanisms of resistance.

  2021cites this paper
• Measuring Line Pressure in Convection-Enhanced Delivery Infusions

  2021cites this paper